A novel genomic island harbouring lsa(E) and lnu(B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 28 02 2019
revised: 28 06 2019
accepted: 24 08 2019
pubmed: 3 9 2019
medline: 5 3 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

A lincosamide-resistant and macrolide-susceptible phenotype has not been described to date in Streptococcus pyogenes [group A streptococcus (GAS)]. The aim of this study was to characterize a GAS isolate susceptible to macrolides but resistant to lincosamide, streptogramin A and pleuromutilin antibiotics. Antimicrobial susceptibility was tested using the microdilution broth method and the resistance phenotype was tested by D-test. The GAS2887HUB isolate was subjected to whole-genome sequencing. The isolate showed a positive Gots' test (clindamycin inactivation). Whole-genome sequencing revealed that the strain was ST10 and emm93, and had five resistance genes [lnu(B), ant(6)-Ia, aph(3')-III, tet(M) and dfrG]. The tet(M) gene was located in a Tn916-like transposon. The lsa(E)-lnu(B)-containing sequence (inserted downstream of the rumA gene) was formed by a 39.6-kb prophage, followed by a gene cluster encoding aminoglycoside-streptothricin resistance [ant(6)Ia-sat4-aph(3')III] and lsa(E)-lnu(B) genes. This structure was not transferred by conjugation. This study identified a new genetic element carrying a determinant of lincosamide resistance in a GAS. Further molecular epidemiological surveys are needed to determine the prevalence of this mechanism of resistance in GAS.

Identifiants

pubmed: 31476434
pii: S0924-8579(19)30237-7
doi: 10.1016/j.ijantimicag.2019.08.019
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
DNA, Bacterial 0
Diterpenes 0
Lincosamides 0
Polycyclic Compounds 0
Streptogramin A 8W4UOL59AZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

647-651

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Dàmaris Berbel (D)

Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spain; Department of Pathology and Experimental Therapeutics, School of Medicine, University of Barcelona, Barcelona, Spain.

Jordi Càmara (J)

Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spain; Department of Pathology and Experimental Therapeutics, School of Medicine, University of Barcelona, Barcelona, Spain.

Ernesto García (E)

CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spain; Centro de Investigaciones Biológicas-CSIC, Madrid, Spain.

Fe Tubau (F)

Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spain; Department of Pathology and Experimental Therapeutics, School of Medicine, University of Barcelona, Barcelona, Spain.

François Guérin (F)

CHU de Caen, Service de Microbiologie, Caen, France; Université de Caen Normandie, EA4655 U2RM (Équipe 'Antibio-résistance'), Caen, France.

Jean-Christophe Giard (JC)

Université de Caen Normandie, EA4655 U2RM (Équipe 'Antibio-résistance'), Caen, France.

M Ángeles Domínguez (MÁ)

Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology and Experimental Therapeutics, School of Medicine, University of Barcelona, Barcelona, Spain.

Vincent Cattoir (V)

CHU de Rennes, Service de Bactériologie-Hygiène hospitalière, Rennes, France; CNR de la Résistance aux Antibiotiques (laboratoire associé 'Entérocoques'), Rennes, France; Université de Rennes 1, Unité Inserm U1230, Rennes, France.

Carmen Ardanuy (C)

Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER de Enfermedades Respiratorias, ISCIII, Madrid, Spain; Department of Pathology and Experimental Therapeutics, School of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: c.ardanuy@bellvitgehospital.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH